| |
| |
|
| Insider
Information: |
Braunstein Douglas L |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
3,704,541 |
|
|
Indirect Shares
|
35,908,536 |
|
|
| Direct
Value |
$102,910,895 |
|
|
|
Indirect Value
|
$613,432,011 |
|
|
| Total
Shares |
39,613,077 |
|
|
| Total
Value |
$716,342,907 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
1
|
|
Stock
price went up :
|
3
|
1
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
 -41.0%
|
 14.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
JP Morgan Chase & Co |
JPM |
Chief Financial Officer |
2012-12-26 |
470,836 |
2012-12-26 |
109,479 |
Premium* |
|
|
Eagle Pharmaceuticals, Inc. |
EGRX |
Director |
|
0 |
2019-10-25 |
732,777 |
Premium* |
|
|
Corindus Vascular Robotics, Inc. |
CVRS |
Director |
2019-10-29 |
0 |
2019-10-29 |
0 |
Premium* |
|
|
Cardtronics Inc |
CATM |
10% Owner |
2018-02-21 |
0 |
2021-03-09 |
8,658,920 |
Premium* |
|
|
Cantaloupe Inc |
CTLP |
10% Owner |
2023-02-21 |
20,212 |
2023-02-21 |
9,270,694 |
Premium* |
|
|
Tivity Health Inc |
TVTY |
10% Owner |
|
0 |
2020-05-07 |
4,795,310 |
Premium* |
|
|
Talkspace, Inc |
TALK |
|
2024-03-01 |
3,213,493 |
2024-03-01 |
12,341,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-23 |
4 |
AS |
$62.58 |
$12,516 |
I/I |
(200) |
749,708 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-22 |
4 |
AS |
$62.68 |
$411,618 |
I/I |
(6,567) |
749,908 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-21 |
4 |
AS |
$62.56 |
$240,791 |
I/I |
(3,849) |
756,475 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
– – • |
2019-10-18 |
4 |
AS |
$62.61 |
$100,174 |
I/I |
(1,600) |
760,324 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
– – • |
2019-10-17 |
4 |
AS |
$62.58 |
$866,196 |
I/I |
(13,842) |
761,924 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
– – • |
2019-10-16 |
4 |
AS |
$62.50 |
$6,375 |
I/I |
(102) |
775,766 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-15 |
4 |
AS |
$62.63 |
$244,836 |
I/I |
(3,909) |
775,868 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-11 |
4 |
AS |
$60.39 |
$984,419 |
I/I |
(16,300) |
779,777 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-10 |
4 |
AS |
$60.16 |
$471,002 |
I/I |
(7,829) |
796,077 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-08 |
4 |
AS |
$60.03 |
$93,520 |
I/I |
(1,558) |
803,906 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-10-07 |
4 |
AS |
$60.11 |
$294,600 |
I/I |
(4,901) |
805,464 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-09-17 |
4 |
AS |
$60.00 |
$6,000 |
I/I |
(100) |
810,365 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-09-12 |
4 |
AS |
$60.07 |
$12,014 |
I/I |
(200) |
810,465 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-09-11 |
4 |
AS |
$60.06 |
$66,785 |
I/I |
(1,112) |
810,665 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-05-10 |
4 |
S |
$56.14 |
$5,614,000 |
I/I |
(100,000) |
811,777 |
0 |
- |
|
| JPM |
JP Morgan Chase & Co |
Chief Financial OfficerOfficer |
• – – |
2010-06-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
847,951 |
|
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2019-05-09 |
4 |
S |
$57.95 |
$3,431,973 |
I/I |
(59,223) |
911,777 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2016-07-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
950,600 |
|
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • – |
2017-08-09 |
4 |
B |
$48.06 |
$1,001,087 |
I/I |
20,400 |
971,000 |
2.1 |
- |
|
| TALK |
Talkspace, Inc |
See Remarks |
• • • |
2022-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650,000 |
1,665,384 |
0 |
- |
|
| TALK |
Talkspace, Inc |
|
• • – |
2022-09-26 |
4 |
A |
$0.95 |
$159,630 |
D/D |
168,032 |
1,833,416 |
0 |
- |
|
| TALK |
Talkspace, Inc |
|
• • – |
2023-12-01 |
4 |
A |
$2.04 |
$204,761 |
D/D |
100,373 |
1,933,789 |
0 |
- |
|
| TALK |
Talkspace, Inc |
|
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,014 |
1,939,803 |
0 |
- |
|
| TVTY |
Tivity Health Inc |
10% Owner |
– – • |
2020-05-07 |
4 |
D |
$12.20 |
$48,312,000 |
I/I |
(3,960,000) |
4,795,310 |
0 |
- |
|
| CATM |
Cardtronics Inc |
10% Owner |
– – • |
2018-02-21 |
4 |
B |
$22.73 |
$7,510,184 |
I/I |
322,000 |
6,324,730 |
1.5 |
- |
|
91 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
